Progyny (PGNY) PT Raised to $31 at Citizens on Post-Q1 EBITDA Estimate Raise

May 11, 2026 4:09 AM

Citizens analyst Constantine Davides raised the price target on Progyny (NASDAQ: PGNY) to $31.00 (from $30.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found